Socioeconomic characteristics and costs of rare and orphan diseases in Peru, 2019: Características socioeconómicas y costos de enfermedades raras y huérfanas en el Perú, 2019

Descripción del Articulo

Introduction: The rare and orphan diseases (ROD) constitute a current challenge due to the lack of investigation. Objective: Describe the socioeconomic characteristics of rare and orphan diseases (ROD) in Peru, 2019. Methods: Descriptive observational des...

Descripción completa

Detalles Bibliográficos
Autores: Claussen Portocarrero, Grecia, Gutierrez Aguado, Alfonso
Formato: artículo
Fecha de Publicación:2021
Institución:Universidad Ricardo Palma
Repositorio:Revistas - Universidad Ricardo Palma
Lenguaje:español
inglés
OAI Identifier:oai:oai.revistas.urp.edu.pe:article/3936
Enlace del recurso:http://revistas.urp.edu.pe/index.php/RFMH/article/view/3936
Nivel de acceso:acceso abierto
Materia:Enfermedades raras
costo de enfermedad
economía
economía de la salud
Perú
Rare diseases
cost of illness
economics
health economics
Peru
Descripción
Sumario:Introduction: The rare and orphan diseases (ROD) constitute a current challenge due to the lack of investigation. Objective: Describe the socioeconomic characteristics of rare and orphan diseases (ROD) in Peru, 2019. Methods: Descriptive observational design. The information was obtained from FISSAL administrative records, and an intentional sample of 20 patients was taken to carry out the questionnaire on ROD. For the economic records, a review of the public budget of the MEF was made. The data analysis was descriptive and inferential. Results: There were 454 patients with a total of 49 ROD; of these, the most representative age groups were schoolchildren and young adults (18% each), and the most frequent diagnosis was Tetralogy of Fallot (22%). The questionnaire on ROD reports a median of 7 months in the delay of diagnosis and between 3 and 5 doctors were visited. Likewise, 30% considered that it generated a high to very high expense. It was calculated that the ROD budget constitutes 2.25% of the total budget for high-cost diseases. Likewise, the ROD budget was different between 2014 and 2019. Conclusions: The population with ROD in Peru is not large; however, it requires greater attention to access to health services and a greater budget allocation.
Nota importante:
La información contenida en este registro es de entera responsabilidad de la institución que gestiona el repositorio institucional donde esta contenido este documento o set de datos. El CONCYTEC no se hace responsable por los contenidos (publicaciones y/o datos) accesibles a través del Repositorio Nacional Digital de Ciencia, Tecnología e Innovación de Acceso Abierto (ALICIA).